Clinical Trial Update: A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is recruiting to evaluate sodium thiosulfate for reducing hearing loss in children with medulloblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Drugs mentioned

• Sodium thiosulfate (sodium thiosulfate)

Snippet

Sponsor: Children's Oncology Group | Conditions: Childhood Medulloblastoma | Phase 3 | Status: RECRUITING